Biomarkers in Lung Diseases: from Pathogenesis to Prediction to New Therapies
The study of protein, lipid, genetic, and genomic biomarkers of lung disease is an important tool for understanding the biology of human lung disease. Both candidate biomarker approaches and high dimensional platforms can provide new insights into pathogenesis and confirmation of the clinical relevance of experimental findings. In recognition of the central role that biomarker research plays in bridging basic and clinical research in human lung disease, the American Journal of Physiology Lung Cellular and Molecular Physiology is issuing a call for papers on the topic of “Biomarkers in Lung Disease: from Pathogenesis to Prediction”. This call for papers requests high-quality studies of human disease biomarkers in patient samples and tissues that enhance our understanding of the pathogenesis of human lung diseases such as Pulmonary Arterial Hypertension, Pulmonary Fibrosis, Acute Lung Injury, COPD, Acute Lung Injury and Lung Cancer. A number of reviews by experts in the field will also be solicited.
All papers will be reviewed promptly, thoroughly, and fairly by members of the Editorial Board and guest reviewers who are recognized experts in this field. Accepted manuscripts will be published on line within two weeks after acceptance under a distinct heading and will receive special attention and handling. Only those papers not requiring extensive revision will be published under this Highlighted Topic.
The deadline for this Call for Papers is December 31, 2015